APA (7th ed.) Citation

Hattori, A., Nishikawa, K., Ito, K., Tachikawa, N., Fujibe, K., Tanaka, S., . . . Hataji, O. (2022). Pseudoprogression of lung large cell neuroendocrine carcinoma resembling pancreatic cancer during durvalumab therapy. Clinical Journal of Gastroenterology, 15(3), 668-672. https://doi.org/10.1007/s12328-021-01588-z

Chicago Style (17th ed.) Citation

Hattori, Aiji, Kenichiro Nishikawa, Kentaro Ito, Namie Tachikawa, Kodai Fujibe, Syota Tanaka, Michiaki Oiwa, and Osamu Hataji. "Pseudoprogression of Lung Large Cell Neuroendocrine Carcinoma Resembling Pancreatic Cancer During Durvalumab Therapy." Clinical Journal of Gastroenterology 15, no. 3 (2022): 668-672. https://doi.org/10.1007/s12328-021-01588-z.

MLA (9th ed.) Citation

Hattori, Aiji, et al. "Pseudoprogression of Lung Large Cell Neuroendocrine Carcinoma Resembling Pancreatic Cancer During Durvalumab Therapy." Clinical Journal of Gastroenterology, vol. 15, no. 3, 2022, pp. 668-672, https://doi.org/10.1007/s12328-021-01588-z.